Artificial heart company Bivacor names Jim Dillon new CEO
Jim Dillon has been named CEO of Bivacor, which is developing a product called the Total Artificial Heart. Click through to the story to learn more about the company's latest accomplishments.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Olivia Pulsinelli Source Type: news
More News: Cardiology | Health Management | Heart | Heart Transplant | Learning | Pharmaceuticals | Universities & Medical Training